Answer
Its selected UK licences require use with encorafenib. The treatments block different points in the BRAF–MEK signalling pathway.
Sources for this answer
- Mektovi 15 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.